article

Drug Target Review – Issue 2 2020

Posted: 26 May 2020 | | 1 comment

In this issue authors discuss the development of COVID-19 antibody therapies, how high-throughput screening enhances research at the Crick Institute and why combinations of immuno-oncology drugs could revolutionise treatment of advanced cancers. Also included in the issue are articles on stem cells and imaging.

This issue includes:

  • SCREENING
    High-throughput screening as a method for discovering new drugs
    Matthew Lloyd, University of Bath
  • ANTIBODIES
    Antibodies against viral disease: highlighting technologies behind COVID-19 antibody therapy
    Shalom Gurjar, OXGENE
  • IMMUNO-ONCOLOGY
    Neoantigens: presenting new vaccine opportunities in immuno-oncology
    Nikki Withers, Drug Target Review
  • IMAGING
    Data, data and still more data: the challenges of imaging and analysing 3D cell models
    Margaritha Mysior, University College Dublin
    Jeremy Simpson, University College Dublin
  • STEM CELLS
    Application of organoid technology for retinal disease modelling and drug discovery
    Valeria Chichagova, Newcastle University and Newcells Biotech

 

The rest of this content is restricted - login or subscribe free to access

Issue 2 2021Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 


Send this to a friend